Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 701–800 of 1,000
Mihai, M. C., Popa, M. A., Șuică, V. I., Antohe, F., Jackson, E. K., Leeners, B., Simionescu, M., & Dubey, R. K. (2021) · Cells · doi:10.3390/cells10092181 · Cited by 10
Copic, D., Direder, M., Schossleitner, K., Laggner, M., Klas, K., Bormann, D., Ankersmit, H. J., & Mildner, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081600 · Cited by 9
“Cell-based therapies have made tangible progress in this field over the past decades [2].”
BackgroundYou, B., Zhang, T., Zhang, W., Pei, Y., Huang, D., Lei, Y., Zhang, S., Qiu, C., Zhang, J., Gu, Z., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106151 · Cited by 9
“Conditioned medium from PO-MSCs (CM), but not extracellular vesicles derived from POMSCs (PO-MSCs-EVs), was crucial for PO-MSCs functions MSCs are recruited to pathological microenvironments and secrete EVs with the same effects as MSCs.21,37 To further confirm whether PO-MSCs regulated the EMT and epithelial barrier…”
BackgroundInfluentialNowzari, F., Zare, M., Tanideh, N., Meimandi-Parizi, A., Kavousi, S., Saneian, S. M., Zare, S., Koohi‐Hosseinabadi, O., Ghaemmaghami, P., Dehghanian, A., et al. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102055 · Cited by 11
Zhai, Z.-H., Li, J., You, Z., Cai, Y., Yang, J., An, J., Zhao, D.-P., Wang, H.-J., Dou, M., Du, R. H., et al. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1203012 · Cited by 9
Станиславович, Д. С., Basalova, N. A., Primak, A. L., Balabanyan, V. Y., Efimenko, A. Y., Никитична, С. М., Popov, V. S., Velichko, A., Дмитриевич, Б. К., Akopyan, Z. A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061608 · Cited by 11
“The entire complex of protein and non-protein molecules (including extracellular vesicles) produced by MSCs comprises MSC secretome, which, according to the results of many studies, stimulates regeneration and exhibits pronounced therapeutic activity in a number of diseases [10,11].”
BackgroundPretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
Xie, Y., Yao, J., Yan, M., Lin, Y., Wei, J., Wang, H., Mao, Y., Liu, P., & Li, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04732-0 · Cited by 9
“Changes in secreted active substances in response to pressures at the local microenvironment are the main mechanism by which MSCs affect adjacent cells and tissues—paracrine mechanism [29].”
BackgroundMerlo, B., & Iacono, E. (2023) · Animals · doi:10.3390/ani13223571 · Cited by 9
“To develop customized therapies for specific tissue injuries, a better understanding of the bioactive factors produced by MSCs derived from different tissue sources is needed [17].”
BackgroundPasternak, K., Szwed, A., Ziemba, B., Pieszyński, I., Bryszewska, M. J., & Kujawa, J. E. (2024) · Lasers in Medical Science · doi:10.1007/s10103-024-04008-z · Cited by 11
“It is assumed that the therapeutic effect of MSCs is mediated by paracrine mechanisms involved in intercellular signaling processes [9, 10].”
Chen, H., Yamaguchi, S., Wang, Y., Kaminogo, K., Sakai, K., & Hibi, H. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03695-3 · Cited by 9
“…terms of tumorigenicity, immune compatibility, transmission of infections, and emboli formation; possible use in allogeneic therapies; and easier production, evaluation, storage, and transportation, enabling the production of CM into ready-to-go biologic products for regenerative medicine [12–14].”
BackgroundExtracellular vesicles and cancer stem cells: a deadly duo in tumor progression
Tayanloo-Beik, A., Eslami, A., Sarvari, M., Jalaeikhoo, H., Rajaeinejad, M., Nikandish, M., Faridfar, A., Rezaei–Tavirani, M., Mafi, A. R., Larijani, B. A., et al. (2024) · Oncology Reviews · doi:10.3389/or.2024.1411736 · Cited by 11
“Furthermore, we can use engineered EVs to deliver therapeutic agents like paclitaxel and lomustine to patients with somatonoma, providing a more precise and targeted therapy [150].”
MethodCalogero, A. M., Viganò, M., Budelli, S., Galimberti, D., Fenoglio, C., Cartelli, D., Lazzari, L., Lehenkari, P. P., Canesi, M., Giordano, R., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13545 · Cited by 11
“3/5/2 PSP-RS: Median (range) 48 (35-59) UPDRS-III: Median (range) 39 (32-51)”
El-Azab, N. E.-E., El‐Mahalaway, A. M., & Sabry, D. (2018) · Journal of Gastrointestinal Cancer and Stromal Tumors · doi:10.4172/2572-4126.1000430 · Cited by 9
“Several researches [41] have appeared supporting the neuroprotective and neurotrophic effects of MSC– CM which contains number of neurothophic factors and has a vital role in modulation of the neurogenic niche.”
BackgroundOktaviono, Y. H., Hutomo, S. A., Farabi, M. J. A., Chouw, A., & Sandra, F. (2020) · F1000Research · doi:10.12688/f1000research.23547.2 · Cited by 9
Lee, S., Heo, J., Ahn, E.-K., Kim, J. H., Kim, Y.-H., Chang, H., Lee, S.-J., Kim, J., & Park, S. J. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3342 · Cited by 10
Kusindarta, D. L., & Wihadmadyatami, H. (2021) · Veterinary World · doi:10.14202/vetworld.2021.2588-2595 · Cited by 13
“, freeze-dried) and without the loss of product potency by eliminating the use of potentially toxic cryoprotective agents [24,25].”
BackgroundBurón, M., Palomares, T., Garrido, P., de la Parte, B. H., García-Alonso, I., & Alonso‐Varona, A. (2022) · Antioxidants · doi:10.3390/antiox11102011 · Cited by 10
“The cytoprotective effect could be due, among other reasons, to the presence in HC016-CM of, on the one hand, various growth factors with mitosis-inducing effects on quiescent cells [48], and on the other hand, apoptosis-inhibiting proteins such as Bcl-2, survivin and Akt [49].”
BackgroundSzabłowska‐Gadomska, I., Rudziński, S., & Dymowska, M. (2023) · BioMed Research International · doi:10.1155/2023/8427200 · Cited by 10
“Furthermore, the storage of secretome is easy and inexpensive compared to that of cells which are routinely stored in liquid nitrogen and require addition of potentially toxic cryoprotectants to sustain cell viability [51].”
BackgroundRegenerative Medicine in Orthopaedics and Trauma: Challenges, Regulation and Ethical Issues
Zamborský, R., Kilian, M., Csöbönyeiová, M., & Danišovič, Ľ. (2018) · Ortopedia Traumatologia Rehabilitacja · doi:10.5604/01.3001.0012.0764 · Cited by 10
Applications of Extracellular Vesicles in Abdominal Aortic Aneurysm
Lu, S., Wang, R., Fu, W., & Si, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.927542 · Cited by 9
Therapeutic potential of exosomes from mesenchymal stromal cells in sepsis
Matvieienko, M. S., Hladkykh, F. V., & Оleksiuk, О. B. (2024) · Karazin Journal of Immunology · doi:10.26565/3083-5615-2024-13-09 · Cited by 8
Napolitano, F., Giudice, V., D’Esposito, V., Prevete, N., Scala, P., de Paulis, A., Selleri, C., Formisano, P., Rossi, F. W., & Montuori, N. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1518412 · Cited by 9
Sánchez-Huerta, V., Quiroz–Mercado, H., Graue-Hernández, E. O., Navas, A., Alford, S., Kharabi, D., & Pflugfelder, S. C. (2025) · Current Therapeutic Research · doi:10.1016/j.curtheres.2025.100799 · Cited by 8
“11 , 12 A key study conducted by Fernandes-Cunha et al, 13 which preceded the development of KPI-012, found that even in the most severe ocular wound model (ie, corneal alkali burn), MSC secretome therapy promoted marked regenerative healing.”
Ali, L., Shaaban, F., Sokhn, E. S., & Saleh, F. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04570-5 · Cited by 11
“…cell-free-based therapies replicate much of the benefits associated with treatments using whole-cell MSCs, including their immunomodulatory and antibacterial effects, while avoiding the risks of immune rejection, emboli formation, and infection transmission associated with MSC transplantation [18].”
Col, V. D., Ribas, F. F., & Araldi, R. P. (2025) · Cosmetics · doi:10.3390/cosmetics12050191 · Cited by 10
Shah, V. P., & Hsu, W. K. (2019) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2019.08.008 · Cited by 8
Mesenchymal stem cells in human health and diseases
El-Hashash, A. H. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819713-4.00011-6 · Cited by 10
Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigenic Agents
Liu, S., Sun, X., Li, K., Lin, C., Na, S., Li, B., & Yokota, H. (2021) · Onco · doi:10.3390/onco1020009 · Cited by 10
“For instance, MSCs may present considerable advantages over other cells for manufacturing, storage, handling, and their potential as ready-to-go biologic products [74].”
BackgroundMolaei, S., Amiri, F., Salimi, R., Ferdowsi, S., & Bahadori, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07785-4 · Cited by 9
Encapsulation of HaCaT Secretome for Enhanced Wound Healing Capacity on Human Dermal Fibroblasts
Heebkaew, N., Promjantuek, W., Chaicharoenaudomrung, N., Phonchai, R., Kunhorm, P., Sorraksa, N., & Noisa, P. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00732-z · Cited by 9
Nowroozzadeh, M. H., Ghazanfari, S., & Sanie‐Jahromi, F. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08496-0 · Cited by 8
“In addition to its transient biological effect, the secretome (since it does not have cells) almost eliminates the challenges related to immune system stimulation, and seems to be promising as an effective and safe biological product in the field of regenerative medicine [21, 22].”
BackgroundHUANG, Y., Huili, Y. A. N. G., Yang, B., ZHENG, Y., Hou, X., Chen, G., ZHANG, W., Xiang, Z. E. N. G., & Du, B. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60445-5 · Cited by 13
Reina, C., Cardella, C., Pinto, M. L., Pucci, G., Acuto, S., Maggio, A., & Cavalieri, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713191 · Cited by 10
“In recent years, CM derived from Wharton’s jelly mesenchymal stem cells extracted from the human umbilical cord has received significant attention due to the high content of bioactive molecules making it theoretically optimal for treating various disorders and injuries [45].”
BackgroundFerreira‐Baptista, C., Ferreira, R. M., Fernandes, M. H., Gomes, P. S., & Colaço, B. (2023) · Veterinary Sciences · doi:10.3390/vetsci10120673 · Cited by 9
“The factors secreted by ADSCs can be manufactured, freeze-dried, packaged, and transported more easily [130–132], thus avoiding the problems related to the use of fresh or frozen ADSCs, since the cell viability of these cells after cryopreservation is controversial [133,134].”
BackgroundNueva era de la medicina basada en las células madre mesenquimales: bases, retos y perspectivas
Vizoso, F. J., Costa, L. A. M. D., & Eiró, N. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2023.10.002 · Cited by 12
Self-citationHolvoet, P. (2023) · Cells · doi:10.3390/cells12242785 · Cited by 8
“Currently, one aims to move from cell-based to cell-free therapy with extracellular exosomes of stem cell origin [20], further reducing the immunogenic response and thus improving the safety and increasing the stability upon storage and obtaining a better targeting of the cells and tissues to be…”
BackgroundGuo, W., Xu, Y., Liu, X., Dou, J., & Guo, Z. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14606 · Cited by 12
“6,7 In addition, compared with other stem cells, ADSCs have the advantages of rich source, easy access, high yield, and low immunogenicity, which lays a cytological foundation for ADSCs cell transplantation in cardiovascular diseases.”
BackgroundAssunção-Silva, R. C., Pinho, A. G., Cibrão, J. R., Pereira, I. M., Monteiro, S., Silva, N. A., Campos, J., Rebelo, A. L., Schlosser, G., Pinto, L., et al. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314231203824 · Cited by 8
“38,41 Importantly, the use of secretome derivatives could bypass potential issues associated with cell transplantation including the number of available cells for transplantation and their survival after this procedure, immune compatibility, tumorigenicity, and infection transmission.”
BackgroundÖzkan, S., Işıldar, B., Sahin, H., Saygı, H. İ., Konukoğlu, D., & Koyutürk, M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122543 · Cited by 10
Conditioned medium of human mesenchymal stem cells affects stem cell senescence in osteoporosis
Liu, K., Sakai, K., Watanabe, J., Dong, J., Maruyama, H., Li, X., & Hibi, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149858 · Cited by 8
Wang, Y., Piao, C., Liu, T., Lu, X., Ma, Y., Zhang, J., Ma, H., & Wang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126604 · Cited by 8
Equine Corneal Wound Healing Using Mesenchymal Stem Cell Secretome: Case Report
Casado-Santos, A., González‐Cubero, E., González‐Fernández, M. L., González-Rodríguez, Y., García-Rodríguez, M. B., & Villar‐Suárez, V. (2024) · Animals · doi:10.3390/ani14131842 · Cited by 8
“The ASC secretome, a rich milieu of trophic factors, cytokines, and extracellular vesicles, has been shown to modulate various cellular processes crucial for wound healing, including inflammation, angiogenesis, and extracellular matrix remodeling [20,21].”
BackgroundZhang, J., Wu, P., & Wen, Q. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03828-8 · Cited by 9
“MSC-derived EV is a lipid bilayer vesicle, which is rich in integrins, transmembrane proteins, ligands of cell surface receptors, signal transduction proteins, as well as genetic materials such as DNA, RNA, and miRNA [26].”
BackgroundRole of exosomes in modulating non-small cell lung cancer radiosensitivity
Fang, J., Rao, X., Wang, C., Wang, Y., Wu, C., & Zhou, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1471476 · Cited by 12
“Furthermore, MSCs control tumor cell growth by secreting various substances, such as cytokines, chemokines, and growth factors (Wang et al., 2022; Vizoso et al., 2017).”
Anoop, G., Kamaraj, M., Nithya, T. G., Babu, P. R., & Babu, S. S. (2025) · Cell and Tissue Banking · doi:10.1007/s10561-025-10167-2 · Cited by 8
“However, variations in processing conditions can alter growth factors and cytokine levels, affecting therapeutic potential (Grzywocz et al. 2014; Vizoso et al. 2017; Ahangar et al. 2020).”
Chen, W. H., Feng, Q., Zhang, C., Yang, L., & Qi, J. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12658 · Cited by 10
“Recent studies have demonstrated that their derived exosomes are effective in minimizing unfavorable side effects in comparison to stem cells themselves, and are emerging as a promising tool for cell-free therapy [10, 11].”
Metabolic Profiling of the Mesenchymal Stem Cells’ Secretome
Gilany, K., Masroor, M. J., Minai‐Tehrani, A., Mani‐Varnosfaderani, A., & Arjmand, B. (2019) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-27727-7_3 · Cited by 8
Kim, O., Hong, H., Seo, H., Kwak, B. J., Choi, H. J., Kim, K., Ahn, J., Lee, S. C., & Kim, S. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i1.70 · Cited by 8
Yuan, T., Xie, Y., & Yang, Y. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220223092905 · Cited by 9
Gugliandolo, A., Diomede, F., Pizzicannella, J., Chiricosta, L., Trubiani, O., & Mazzon, E. (2022) · Biomedicines · doi:10.3390/biomedicines10030683 · Cited by 12
“As reported, the capacity of MSCs to provide regeneration is a secretome-based process, which has become more common as a strategy to discover novel therapeutic targets [9].”
BackgroundInfluentialDilogo, I. H., Fiolin, J., Canintika, A. F., Pawitan, J. A., & Luviah, E. (2022) · PubMed Central · doi:10.22038/abjs.2021.49539.2458 · Cited by 8
“Possibility for mass-production with tailor-made characteristics and availability for acute conditions treatment is one of the main advantages of secretome over MSC (6).”
BackgroundIravani, K., Mehrabani, D., Doostkam, A., Azarpira, N., Iranpour, P., Bahador, M., & Mehravar, S. (2022) · Current Therapeutic Research · doi:10.1016/j.curtheres.2022.100682 · Cited by 9
Siddiqi, S., Klomjit, N., Jiang, K., Conley, S. M., Zhu, X., Saadiq, I. M., Ferguson, C. M., Tang, H., Lerman, A., & Lerman, L. O. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10443-8 · Cited by 9
“When administered in-vivo, these immuno-privileged cells exert their therapeutic effects largely though their secretome [7].”
BackgroundSendón-Lago, J., Seoane, S., Saleh, F., García‐Caballero, L., ARIAS, M. E., Eiró, N., MACIA, M., Vizoso, F. J., Pérez-Fernández, R., & Schneider, J. (2022) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20341 · Cited by 8
Self-citationTan, Y., Cai, J., & Wang, Z. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac090 · Cited by 8
“On the other hand, this cell-free treatment may provide a new paradigm for MSC therapy [38].”
BackgroundJoshi, J. M., Muttigi, M. S., Upadhya, R., & Seetharam, R. N. (2023) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2023.2180388 · Cited by 10
“The environment may be regulated by maintaining the oxygen levels, exposing the MSCs to cytokines, the growth conditions in culture, or a combination of one or more of them [44,45].”
BackgroundZhou, Y., Zhao, Y., Wu, Y., Chen, J., Wu, H., Wei, W., & Yan, S. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230428094400 · Cited by 8
Sari, M. I., Jusuf, N. K., Munir, D., Putra, A. B., Bisri, T., Ilyas, S., Farhat, F., Muhar, A. M., Rusda, M., & Amin, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11082325 · Cited by 10
“Mesenchymal stem cells (MSCs) have drawn much interest for their immunomodulatory effects [24].”
BackgroundIşıldar, B., Özkan, S., & Koyutürk, M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300216 · Cited by 14
Diedrichs, F., Stolk, M., Jürchott, K., Haag, M., Sittinger, M., & Seifert, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01716 · Cited by 10
Sendera, A., Pikuła, B., Maziarz, A., Kocan, B., & Banaś-Ząbczyk, A. (2020) · Archives of Biological Sciences · doi:10.2298/abs200321028t · Cited by 9
“However, this therapy might not require the use of whole MSCs but their secretome derivatives, such as conditioned media or exosomes, which provide therapeutic effects [22,23].”
BackgroundAlonso-Alonso, M. L., Srivastava, G. K., Usategui‐Martín, R., García-Gutiérrez, M. T., Jimeno, J. C. P., & Fernandez‐Bueno, I. (2020) · Stem Cells International · doi:10.1155/2020/9463548 · Cited by 9
“Knowledge of these elements will facilitate the approach of cell therapy using their secretome-based PhC, which not only represents a safer alternative to living cell transplant [16] but also allows more quality control and facilitates dosing [25].”
BackgroundRasaei, R., Kim, E., Kim, J.-Y., Na, S., Kim, J., Heo, J., Shin, D., Choi, S. S., & Hong, S. (2020) · Biomedicines · doi:10.3390/biomedicines8090346 · Cited by 8
“Recent studies demonstrated that the benefits of MSC therapy could be due to their secretions, which play an important role in the regeneration of damaged tissues and may present considerable advantages over cell-based applications for manufacturing, handling and storage [29].”
BackgroundChin, Y., Liu, C.-M., Chen, T.-Y., Chung, Y.-Y., Lin, C.-Y., Hsiung, C.-N., Jan, Y.-S., Chiu, H., Fu, E., & Lee, S. (2020) · Journal of Dental Sciences · doi:10.1016/j.jds.2020.10.014 · Cited by 10
“Conditioned medium (CM) from adult stem cells, particularly MSCs, contains growth factors, cytokines, and other active substances and has been revealed to mimic the regulatory effects of stem cells on immunocompetent cells.(20,21) CM from adipose stem cells was reported to enhance the secretion of the anti-inflammator…”
BackgroundAlijani-Ghazyani, Z., Roushandeh, A. M., Sabzevari, R., Salari, A., Toosi, M. T. R., Jahanian‐Najafabadi, A., & Roudkenar, M. H. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105897 · Cited by 9
Romaniyanto, R., Prakoeswa, C. R. S., Tinduh, D., Notobroto, H. B., Rantam, F. A., Utomo, D. N., Suroto, H., & Ferdiansyah, F. (2021) · Indonesian Journal of Biotechnology · doi:10.22146/ijbiotech.63318 · Cited by 9
Wang, Z., Zhang, X., Qi, L., Feng, W., Gu, Y., & Ding, Y. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02204-7 · Cited by 8
“More and more papers attribute the effects of MSCs to the MSCs-derived secretome including growth factors, cytokines, anti-inflammatory mediators and exosomes [18].”
BackgroundLu, X., Wang, Y., Piao, C., Li, P. A., Cao, L., Liu, T., Ma, Y., & Wang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313069 · Cited by 7
Optimizing mesenchymal stromal cells priming strategies for tailored effects on the secretome
González-Rodríguez, Y., Casado-Santos, A., González‐Cubero, E., González‐Fernández, M. L., Sellés-Egea, A., & Villar‐Suárez, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118218 · Cited by 10
Mirzaahmadi, B., Ahmadian, S., Haddadi, P., Nezhad‐Mokhtari, P., Nezamdoust, F. V., Yalameha, B., Chegeni, S. A., Rashidi, S., Mousakhani, A., Sokullu, E., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02286-w · Cited by 11
“Despite the significant impact of stem cells in revascular-ization-based therapies, the possibility of immune rejection, activation of alloreactive immune cells, difficulties associated with isolation, purification, etc., has caused biologists and clinicians to use stem cell secretome [15].”
Song, Y., Wang, X., Yan, X., Li, X., Han, X., Zhang, Y., Wang, Y., Chen, X., Li, X., Zhang, X., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00444-9 · Cited by 8
Alrushaid, N., Alqurashi, N., Alobaidi, B. S., & Khan, F. A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1729022 · Cited by 7
“To overcome the inherent variability and sometimes modest potency of native secretome, several groups have engineered MSCs or amniotic epithelial cells (AECs) to overexpress anticancer proteins or to act as “ micro-pharmacies ” that actively load and release chemotherapeutic drugs (38 – 40).”
Negrete-Diaz, F., Martinez-Rodriguez, S., Guedan-Duran, A., Romero-Lopez, A., & Panetsos, F. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108245 · Cited by 11
Gouveia, D., Correia, J., Cardoso, A., Carvalho, C., Oliveira, A. C., de Almeida, A. P., Gamboa, Ó., Ribeiro, L., Branquinho, M., Sousa, A. C., et al. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1192744 · Cited by 9
Pang, K., Kong, F., & Wu, D. (2023) · Biomedicines · doi:10.3390/biomedicines11092343 · Cited by 8
“Author Contributions: Conceptualization, D.W. and K.P.; methodology, K.P.; software, K.P.; validation, K.P. and F.K.; formal analysis, K.P. and F.K.; investigation, K.P. and F.K.; resources, D.W.; data curation, K.P.; writing—original draft preparation, K.P.; writing—review and editing, D.W.;”
León-Moreno, L. C., Reza-Zaldívar, E. E., Hernández-Sapiéns, M. A., Villafaña-Estarrón, E., García-Martín, M. C., Ojeda-Hernández, D. D., Matías‐Guiu, J. A., Gómez‐Pinedo, U., Matías‐Guiu, J., & Canales-Aguirre, A. A. (2023) · Biomolecules · doi:10.3390/biom14010008 · Cited by 9
“In this line, preclinical studies support the use of MSC-derived exosomes in neural regeneration approaches [122–125].”
ResultAdvances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells
Rajput, S., Malviya, R., & Uniyal, P. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128296105240305110312 · Cited by 13
Cui, L., Li, D., Xu, J., Li, H., Pan, Y., Qiu, J., Peng, S., Wang, Y., Wang, C., Wang, J., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09878-8 · Cited by 8
“…the proliferation, migration, and inflammatory miRNAs are known to regulate a range of physiologi - cal and pathological processes, including cell proliferation, apoptosis, differentiation, and even tumorigenesis and development, making them a focal point in regulatory mechanisms [29, 30].”
Rasouli, M., Alavi, M., D’Angelo, A., Sobhani, N., Roudi, R., & Safari, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113265 · Cited by 10
Elhamipour, M., Soleimanjahi, H., Abdoli, A., Sharifi, N., Karimi, H., jahi, S. S., & Kvistad, R. (2024) · Intervirology · doi:10.1159/000542356 · Cited by 7
“Considering potential side effects of using adipose-derived MSCs, such as embolism and transmission of infection, researchers have used endocrine secretions of these cells called secretome [28, 32 – 34].”
Gao, Q., Su, Z., Pang, X., Chen, J., Luo, R., Li, X., Zhang, C., & Zhao, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04651-1 · Cited by 7
“Their therapeutic efficacy is primarily attributed to paracrine factors rather than direct cell replacement or differentiation [28, 29].”
Standardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model
Wolint, P., Hofmann, S., von Atzigen, J., Böni, R., Miescher, I., Giovanoli, P., Calcagni, M., Emmert, M. Y., & Buschmann, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010291 · Cited by 8
Pinheiro-Machado, E., de Haan, B. J., Engelse, M. A., & Smink, A. M. (2025) · Cells · doi:10.3390/cells14040302 · Cited by 7
“Several studies, both in vitro and in T1DM animal models, have demonstrated the effectiveness of co-culturing/co-transplantation of islets with MSCs, including ASCs, showing enhanced insulin secretion, reduced beta cell apoptosis, and increased beta cell mass [6,7,9,16–20].”
Wolint, P., Miescher, I., Mechakra, A., Jaeger, P. K., Rieber, J., Calcagni, M., Giovanoli, P., Viola Vogel, B., Snedeker, J. G., & Buschmann, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083622 · Cited by 7
“Through trophic and paracrine mechanisms [28,39], the inhibition of lymphocyte proliferation was observed, leading to an anti-inflammatory effect and accompanied by improved functional and biomechanical outcomes in tendon and ligament healing using MSC-derived secretomes [40].”
Xie, Y., Yi, Q., Xu, C., Wang, Y., Jiang, Y., Feng, Y., Wang, L., Yang, H., Zhang, Y., & Wang, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04313-6 · Cited by 9
Munoz-Perez, E., Igartúa, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145104 · Cited by 7
Tarar, A. A., Alyami, E. M., & Peng, C. (2021) · RSC Advances · doi:10.1039/d0ra10263f · Cited by 7
Widjaja, S. L., Salimo, H., Julianto, I., & Soetrisno (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.04.034 · Cited by 7
Svitlana, R., Pikus, P. O., Buchek, P., Nadiia, S., Ianina, P., Dmytro, I., & Vitaly, K. (2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac124.50545070 · Cited by 7
Nesteruk, H., Alabedalkarim, N. M., Колот, Н. В., Комароми, Н. А., Protsenko, O. S., & Легач, Є. (2022) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2022.2.13 · Cited by 7
Huang, P., Qin, X., Fan, C., Wang, M., Chen, F., Liao, M., Zhong, H., Wang, H., & Ma, L. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00538-9 · Cited by 9
“Therefore, cellfree MSC derivatives are also proposed [34, 35].”
BackgroundZheng, X., Zhao, D., Liu, Y., Jin, Y., Liu, T., Li, H., & Liu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115739 · Cited by 7
Dilogo, I. H., & Fiolin, J. (2019) · Annual Research & Review in Biology · doi:10.9734/arrb/2019/v31i230045 · Cited by 7
“Secretome-based approaches using CM may present osteogenic potential advantages over living cells regarding manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biological therapeutic agent [34-41].”
BackgroundKc, P., Shah, M., Shaik, R., Hong, Y., & Zhang, G. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00788 · Cited by 7
Santos, A. C. A., Sartori, T., Borelli, P., & Fock, R. A. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102210 · Cited by 7
Mesenchymal Stem Cell-derived Extracellular Vesicles for Skin Wound Healing
Kim, S., Park, J., & Kim, T. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6064-8_18 · Cited by 7
Teshima, T., Yasumura, Y., Suzuki, R. H., & Matsumoto, H. (2022) · Viruses · doi:10.3390/v14081687 · Cited by 8
Biological Aging Parameters Can Be Improved After Autologous Adipose-Derived Stem Cell Injection
Son, H.-Y., Bae, H.-S., Son, Y., Kim, S., Hong, H.-S., & Park, J.-U. (2018) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000004932 · Cited by 7
Tan, S. T., Firmansyah, Y., & Elizabeth, J. (2020) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2020.v4.i2a.49 · Cited by 10
“It is also worth mentioning that the secretomes of MSCs have anti-fibrotic and angiogenic effects, which can reduce scar tissue formation when given early ([39]).”
BackgroundInterleukins Profiling in Umbilical Cord Mesenchymal Stem Cell-Derived Secretome
Chouw, A., Sartika, C. R., Milanda, T., & Faried, A. (2022) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s356763 · Cited by 10
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.